Canon Inc., together with its subsidiaries, develops, produces, sells, and services various printing, medical, imaging, and industrial equipment in Japan, the Americas, Europe, Asia, and Oceania.
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price4,273.00 JPY
Fair value4,193.64
Ethical score70.0/100
RatingAVOID
Our investment reviews on this name
2026-08-23Read Distribution4,273.00+0.0% to today
2026-07-23Read Accumulation4,273.00+0.0% to today ✓
2026-07-03Read Distribution4,273.00+0.0% to today
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Canon Inc. holds its Markup at $4,273.00. The statistical read favours the sellers, held for 34 days.
As held on the ledger · 2025-12-31
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 34 days
Price at the screen
$4,273.00
Valuation
11.64 trailing · 11.79 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.25
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
15.42%
Below 33%
Interest-bearing debt is just 15.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.53%
Below 33%
Cash held in interest-bearing accounts and securities is 0.5% of assets, under the one-third limit.
Pass
Receivables
21.51%
Below 49%
Money owed to the company is 21.5% of assets, under the 49% limit.
Pass
Revenue purity
0.32%
Below 5%
Only 0.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades above our $4,193.64 fair value estimate, 3.30% revenue growth.
Fair value range in JPY, drawn from the 2025-12-31 screen. The gold marker is the market price at the same screen. The price runs 1.9% above the base estimate.
Third-party analyst targets: 10 covering, consensus None. The average target sits +9% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2025-12-31 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it gives us pause
At 11.8x forward earnings, the price already runs ahead of the business. It trades 2% above our $4,193.64 fair value, so you would be buying at a premium, not a discount.
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
7751.T trades on TSE (the company is based in Japan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (10 analysts) rates it hold, with a mean price target of $4800.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (10 analysts) rates it hold, with a mean price target of $4800. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-22Distribution$4,273.00+0.0%Entry 9
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (10 analysts) rates it hold, with a mean price target of $4800. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-21Distribution$4,273.00+0.0%Entry 8
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (10 analysts) rates it hold, with a mean price target of $4800. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-20Distribution$4,273.00+0.0%Entry 7
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (10 analysts) rates it hold, with a mean price target of $4800. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-19Distribution$4,273.00+0.0%Entry 6
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (10 analysts) rates it hold, with a mean price target of $4800. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Distribution$4,273.00+0.0%Entry 5
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (10 analysts) rates it hold, with a mean price target of $4800. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-17Distribution$4,273.00+0.0%Entry 4
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (10 analysts) rates it hold, with a mean price target of $4800. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-16Distribution$4,273.00+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (10 analysts) rates it hold, with a mean price target of $4800. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-03Distribution$4,273.00+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
Period
Price then
Price return
Divs per share
$1,000 became
Total return
1 month
$4,092.00
+5.7%
·
$1,057
+5.7%
2 months
$4,370.00
-1.1%
·
$990
-1.1%
3 months
$4,460.00
-3.1%
·
$970
-3.1%
6 months
$4,699.83
-8.0%
$80.00
$937
-6.3%
1 year
$4,174.74
+3.6%
$160.00
$1,074
+7.4%
2 years
$4,268.51
+1.3%
$315.00
$1,087
+8.7%
3 years
$3,217.32
+34.4%
$455.00
$1,485
+48.5%
5 years
$2,173.92
+98.9%
$675.00
$2,299
+129.9%
Historical returns from market close data. Past performance does not guarantee future results.
The Ledger's Promise
This entry now belongs to the ledger. Whatever 7751.T does next, these words stay.
Canon Inc. · 7751.T · Markup · $4,273.00
Recorded 2025-12-31 · before the outcome · scored mechanically